St Jude Medical receives CE Mark approval Quadra Allure MP cardiac resynchronization therapy pacemaker
St Jude Medical has received CE Mark approval for the world’s first and only ‘MultiPoint Pacing’ Pacemaker.
The Quadra Allure MP cardiac resynchronization therapy pacemaker (CRT-P) is a game changer for cardiac patients.
With the MultiPoint Pacing option, doctors can customise CRT pacing based on patient need and reducing the rate of CRT non-responders.
Cardiac surgeons are also very excited about this new technology, like Dr Francesco Zanon, study investigator and director of the electrophysiology unit at the Department of Cardiology at Santa Maria della Misericordia Hospital in Rovigo, Italy.
He said: “From our initial experience, we think MultiPoint Pacing improves cardiac function, resulting in better resynchronization, and could be a further advantage of CRT. We observed significant improvement over traditional CRT pacing, and therefore believe this technology could have wide application because it is accessible for all CRT implanters.”
St Jude Medical’s introduction of the Quadra Allure MP CRT-P expands its suite of heart failure intervention products designed to support the care of approximately 26 million people worldwide who suffer from heart failure. This technology portfolio includes other cutting-edge technologies such the CardioMEMS HF Monitoring System, implantable cardioverter defibrillators (ICD), quadripolar and multi-point pacing systems.